- Rating
- 1
- Confidence
- 3
- Informativeness
- 1
- Presentation
- 2
- Soundness
- 1
Read review
Paper summary
The paper proposes GaitDiffusion, a two-stage latent diffusion model that generates full-body Parkinsonian gait conditioned on the UPDRS gait score. The first stage is a VAE trained with an auxiliary UPDRS classification loss and a class-prototype loss. The second stage is a DiT in that latent space, trained with an additional ROM loss. On four CARE-PD cohorts, the paper reports that the per-class mean ROM of the generated gait decreases with severity as in real gait, and that the generated gait closely reproduces the real data.
Critical strengths
The problem is difficult and worth studying. Parkinsonian gait combines several changes, such as reduced stride amplitude and arm swing from bradykinesia and rigidity, stooped posture, asymmetry, and episodic freezing of gait. These differ only subtly between adjacent severity levels but vary widely across patients, and clinical data are scarce and imbalanced across levels. The paper also reports its results in detail, per class and per joint (Tables 1 and 2), which makes them easy to interpret.
Critical weaknesses
W1. Little in the method is new, and the key comparisons are not controlled.
Most components already exist: latent motion diffusion (MLD), DiT with AdaLN-Zero and CFG, and x0-prediction with kinematic losses (MDM). Benasco et al. (2026), cited in the paper, already uses the same diffusion setup for gait.
Besides the ROM loss, the new parts are the surrogate and prototype losses in the VAE, and these are not ablated (Table 4), although the conclusion says the ablation confirms their role. The VAE stage itself is not compared with diffusion directly in motion space as in MDM, and its reconstruction accuracy is not reported. The continuous-versus-discrete question is also left open, since the GAITGen numbers in Table 3 were obtained with different training data and a different evaluation protocol (Section 3.1).
Overall, it is unclear what drives the results and what the paper adds beyond existing components.
W2. The generated gait shows little diversity, so the model behaves more like a regression than a generative model.
Gait varies between patients of the same class. In the real data, the U0 to U1 difference in mean ROM (about 5.5°) is smaller than the within-class standard deviation (about 12 to 13°, Table 1), and the data augmentation that motivates the paper (Section 1) depends on reproducing this variation. The generated gait does not seem to do so. For U0–U2, its within-class ROM spread is roughly one fifth to one eighth of that of real gait (Table 1) and recall is low (Table 2), which the paper attributes to the ROM loss anchoring generation near class-mean amplitudes (Section 3.1).
A model that returns one average gait per class could also reach the low ROM error and the ROM ordering in Table 1, since these are the per-class means that the ROM loss fits directly (Eq. 6). These ROM results therefore do not separate the model from a class-conditional regression, and such samples would likely reinforce typical patterns rather than add information for augmentation.
Questions for authors
Q1 (W1). Could you add a VAE variant without the surrogate and prototype losses to the ablation, and report the reconstruction accuracy of the VAE? This would show whether these losses are what produce the ROM ordering.
Q2 (W2). Could you compare the per-class spread, not only the mean, of generated and real gait on features that the ROM loss does not use, such as walking speed, stride length, arm swing, and trunk inclination? If the generated gait matches the real within-class variation, my concern in W2 would be reduced.
Q3 (W2). Could you clarify how ROM is defined and from which part of the representation it is computed, what form the generated samples take when fed to the TRTS classifier, and what DTW is computed against? Could you also report subject-level results and confidence intervals over repeated seeds?
3 comments
Thank you for the response and for rerunning the comparison under the GAITGen protocol. I have read it carefully.
Could you clarify whether this submission extends the cited 2026 arXiv preprint or is an independent work? The preprint is listed as an ICNR 2026 paper, so I assess this submission as an independent work and evaluate its contribution on its own.
If you are able to compute any of the requested results before the discussion period ends, namely the ablation of the two losses, the VAE reconstruction accuracy, the within-class spread on features outside the ROM loss, or the items in Q3, I would be glad to see them and will take them into account in my evaluation. Until then, I am keeping my score.
Thanks
Thanks so much for your willingness to take into account the new ablations in the evaluation. However, reviewer dneg is very much in favor of rejection, so nothing will change from the outcome perspective. In any case, ff we manage to deliver all the results on time, we will provide them for the sake of completeness. The GPU is running!
Database and novelty
Thanks so much for the fair evaluation.
W1. We are Benasco et al. and that contribution is an Extended Abstract that we uploaded to arxiv. Thus, that paper should not invalidate the originality of this work. The current presented model is an improved version based on the ideas from that proof-of-concept. Hence, while we agree that the components are not new, the way to connect them and use them to incorporate the ROM is certainly original. Anyway, we think that the parsimony of the model and its diffusion backbone makes it very powerful for future research in gait-conditioned generation.
"Table 3 was obtained with different training data and a different evaluation protocol"
We agree as we replied to Rev 1. We never understood why GaitGen is only trained with PD-GaM and tested with the others. For instance, PD-GaM only has 2 subjects at level 3. Why PD-GaM and not the others? Is this cherry-picked? Or maybe due to compatibility to previous models. Thus, we decided to use all the data that we have and split the training, validation, and test sets by subjects. This is what would really happen in a medical application. You use the maximum amount of databases that you have.
In any case, at the time of submission, GaitGen's code was not yet released, so we reported their results instead of retraining their model. To evaluate your concern, we trained GaitDiffusion with only PD-GaM and tested it on the other databases, achieving performance similar to training with all databases. However, during this rebuttal, we discovered, by checking GaitGen code, that their reported AAMD formula in the paper was different from the one in the code. So the results were misleading in AAMD. Here, you have the results with PD-GaM-only training: AVE ~equal, AAMD 4x worse, ASMD 4x better.
What is missing to evaluate is to train GaitGen with our way of using all databases, which they did not report, but this would require unfortunately more time than the one-week rebuttal as it is not our code.
Q1 (W1). Could you add a VAE variant without the surrogate. We trained the VAE variant without the surrogate and preliminary results support the ROM ordering. But this needs further time to evaluate it properly without rush.
Q2 (W2). per-class spread. We identified that the spreads are slightly collapsed, around 0.3 less than the ground truth as expected by the reviewer. This needs careful inspection to validate our statement that we are properly generating enough different gaits for synthetic data augmentation.
Thanks so much again for the review. We will address all your concerns.